US Congress Senate Bill 61 (Prior Session Legislation)

---

Spectrum: Moderate Partisan Bill (Democrat 10-2-1)
Status: Introduced on January 9 2019 - 25% progression, died in committee
Action: 2019-01-09 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA. Under the bill, certain drugs may not be imported, including controlled substances and biological products. The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.

Safe and Affordable Drugs from Canada Act of 2019

Sen. Chuck Grassley [R-IA]	Sen. Amy Klobuchar [D-MN]	Sen. Jeanne Shaheen [D-NH]	Sen. Tammy Baldwin [D-WI]
Sen. Ron Wyden [D-OR]	Sen. Patrick Leahy [D-VT]	Sen. Sherrod Brown [D-OH]	Sen. Angus King [I-ME]
Sen. Margaret Hassan [D-NH]	Sen. Jeff Merkley [D-OR]	Sen. Sheldon Whitehouse [D-RI]	Sen. Susan Collins [R-ME]
Sen. Gary Peters [D-MI]

Date	Chamber	Action
2019-01-09	Senate	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

HB478 (Same As) 2019-01-25 - Referred to the Subcommittee on Health.
SB3384 (Related) 2020-03-03 - Read twice and referred to the Committee on Finance.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/senate-bill/61/all-info
Text	https://www.congress.gov/116/bills/s61/BILLS-116s61is.pdf